WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced today that Michael Rosenblatt, M.D., executive vice president and chief medical officer for Merck, will deliver a keynote address at the BIO Convention in China, October 24-25, 2012, in Shanghai. The event expects to bring together global biotechnology executives, pharmaceutical companies and investment firms to meet and explore business opportunities within China’s emerging biotech sector.
